investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis
Alan B. Cantor
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Alan B. Cantor
Boston Children's Hospital
Boston, United States
Related projects
Thomas Waldmann
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Leukaemia
Hematology and hematologic malignancies
Ravindra Majeti
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML
Leukaemia
Hematology and hematologic malignancies
Dong-Er Zhang
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
Leukaemia
Hematology and hematologic malignancies
Edward W Harhaj
Mechanisms of HTLV-I Tax Mediated NF-kB Activation
Leukaemia
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Hematology and hematologic malignancies
Scott Durum
Cytokines and T Cell Development
Leukaemia
Hematology and hematologic malignancies
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Hematology and hematologic malignancies
Elizaveta V Benevolenskaya
RBP2 Regulation Through Differential Recruitment to Genomic Loci
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies